116 related articles for article (PubMed ID: 21400552)
1. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis.
di Mambro AJ; Parker R; McCune A; Gordon F; Dayan CM; Collins P
Hepatology; 2011 Apr; 53(4):1316-22. PubMed ID: 21400552
[TBL] [Abstract][Full Text] [Related]
2. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
4. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
Morris JM; Forrest EH
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
[TBL] [Abstract][Full Text] [Related]
5. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
Creed TJ; Norman MR; Probert CS; Harvey RF; Shaw IS; Smithson J; Anderson J; Moorghen M; Gupta J; Shepherd NA; Dayan CM; Hearing SD
Aliment Pharmacol Ther; 2003 Jul; 18(1):65-75. PubMed ID: 12848627
[TBL] [Abstract][Full Text] [Related]
6. Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis.
Shasthry SM; Rastogi A; Bihari C; Vijayaraghavan R; Arora V; Sharma MK; Sarin SK
Virchows Arch; 2018 Apr; 472(4):667-675. PubMed ID: 29516163
[TBL] [Abstract][Full Text] [Related]
7. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone.
Creed TJ; Lee RW; Newcomb PV; di Mambro AJ; Raju M; Dayan CM
J Immunol; 2009 Jul; 183(1):164-71. PubMed ID: 19542427
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
Nguyen-Khac E; Thevenot T; Piquet MA; Benferhat S; Goria O; Chatelain D; Tramier B; Dewaele F; Ghrib S; Rudler M; Carbonell N; Tossou H; Bental A; Bernard-Chabert B; Dupas JL;
N Engl J Med; 2011 Nov; 365(19):1781-9. PubMed ID: 22070475
[TBL] [Abstract][Full Text] [Related]
9. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
[TBL] [Abstract][Full Text] [Related]
10. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.
Mathurin P; Abdelnour M; Ramond MJ; Carbonell N; Fartoux L; Serfaty L; Valla D; Poupon R; Chaput JC; Naveau S
Hepatology; 2003 Dec; 38(6):1363-9. PubMed ID: 14647046
[TBL] [Abstract][Full Text] [Related]
11. Alcoholic hepatitis: Prognosis and treatment.
Casanova J; Bataller R
Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity.
Dhanda AD; di Mambro AJ; Hunt VL; McCune CA; Dayan CM; Dick AD; Lee RW; Collins PL
Hepatology; 2015 Mar; 61(3):1099. PubMed ID: 24811769
[No Abstract] [Full Text] [Related]
14. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.
Spahr L; Rubbia-Brandt L; Frossard JL; Giostra E; Rougemont AL; Pugin J; Fischer M; Egger H; Hadengue A
J Hepatol; 2002 Oct; 37(4):448-55. PubMed ID: 12217597
[TBL] [Abstract][Full Text] [Related]
15. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
Aw MM; Taylor RM; Verma A; Parke A; Baker AJ; Hadzic D; Muiesan P; Rela M; Heaton ND; Mieli-Vergani G; Dhawan A
Transplantation; 2003 Mar; 75(6):796-9. PubMed ID: 12660504
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.
Tkachenko P; Maevskaya M; Pavlov A; Komkova I; Pavlov C; Ivashkin V
Hepatol Int; 2016 Nov; 10(6):983-987. PubMed ID: 27337960
[TBL] [Abstract][Full Text] [Related]
17. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
Louvet A; Diaz E; Dharancy S; Coevoet H; Texier F; Thévenot T; Deltenre P; Canva V; Plane C; Mathurin P
J Hepatol; 2008 Mar; 48(3):465-70. PubMed ID: 18164508
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
Orr DW; Portmann BC; Knisely AS; Stoll S; Rela M; Muiesan P; Bowles MJ; Heaton ND; O'Grady JG; Heneghan MA
Transplant Proc; 2005 Dec; 37(10):4373-9. PubMed ID: 16387124
[TBL] [Abstract][Full Text] [Related]
19. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Alvarez Castro AM; Seijo Ríos S; Molina Pérez E; Castroagudín JF; Varo Pérez E
Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
[TBL] [Abstract][Full Text] [Related]
20. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
